FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Vaccine Advisors Angry at Lack of Transparency

[ Price : $8.95]

Some FDA and CDC vaccine advisors say they should have been given Moderna Covid booster infection data, even though it was early a...

We Agree: FDA Should Jettison Foods

[ Price : $8.95]

FDA Webview editor Jim Dickinson supports a Washington Post editorial board recommendation made after a meeting with the agencys l...

Criminal Probe Nets 2 Guilty Pleas Over Stolen Test Strips

[ Price : $8.95]

An FDA Office of Criminal Investigations probe leads to guilty pleas by Jennifer Robertson (Battle Creek, MI) and Michelle McAllis...

Many Recalled 510(k) Devices Had Recalled Predicates: Study

[ Price : $8.95]

Academic medical center researchers say a loophole in the law allows FDA to clear 510(k) submissions whose predicate was subject t...

Attorneys Look Back, Ahead at FDA

[ Price : $8.95]

SheppardMullin attorneys review FDA 2022 actions in several regulatory areas and look ahead to 2023.

CGMP Violations at Indias Sun Pharmaceutical

[ Price : $8.95]

FDA warns Sun Pharmaceuticals about CGMP violations and other issues in its production of finished drugs in Gujarat, India.

Model-Informed Drug Development Meetings Continue

[ Price : $8.95]

Federal Register notice: FDA announces the continuation of its Model-Informed Drug Development Paired Meeting Program as part of t...

Correction Notice on Advisory Committee Charter Renewal

[ Price : $8.95]

Federal Register notice: FDA corrects a 12/13/2022 notice entitled Advisory Committee; Cardiovascular and Renal Drugs Advisory Com...

Standardizing REMS Information in SPL

[ Price : $8.95]

CDER Office Medication Error Prevention and Risk Management director Claudia Manzo describes the change in REMS format to SPL.

Valisure FDA-483 on Lab Practices Released

[ Price : $8.95]

FDA posts a six-item Form FDA-483 that cites analytical laboratory Valisure over deficient laboratory practices after a 5/26-7/6/2...